If it doesn't work, stop it: “Ineffective” treatments might be in a patient's best interests

Por Jackson, Peter R
Publicado em 2004

What benefit do patients expect from adding second and third antihypertensive drugs?

Por Leaman, Hannah, Jackson, Peter R
Publicado em 2002

CARDIOVASCULAR AND CORONARY RISK ESTIMATION IN HYPERTENSION MANAGEMENT

Por Wallis, Erica J, Ramsay, Lawrence E, Jackson, Peter R
Publicado em 2002

Dysfunctional breathing and asthma : Panic disorder needs to be considered

Por Davies, Simon J C, Jackson, Peter R, Ramsay, Lawrence E
Publicado em 2001

Aspirin for primary prevention : Treatment policy should be based on all trial evidence, not subgroup analysis

Por Ramsay, Lawrence E, Sanmuganathan, Philemon S, Wallis, Erica J, Jackson, Peter R
Publicado em 2000

Treatment of anxiety and depressive disorders in patients with cardiovascular disease

Por Davies, Simon J C, Jackson, Peter R, Potokar, John, Nutt, David J
Publicado em 2004

Statins for primary prevention: at what coronary risk is safety assured?

Por Jackson, Peter R, Wallis, Erica J, Haq, Ifti U, Ramsay, Lawrence E
Publicado em 2001

Comparison of methods of estimating coronary risk : Authors did not use latest version of Sheffield table

Por Wallis, Erica J, Ramsay, Lawrence E, Yikona, Joseph I N M, Jackson, Peter R
Publicado em 2000

Team science and the physician–scientist in the age of grand health challenges

Por Steer, Clifford J., Jackson, Peter R., Hornbeak, Hortencia, McKay, Catherine K., Sriramarao, P., Murtaugh, Michael P.
Publicado no Ann N Y Acad Sci (2017)

Coronary and cardiovascular risk estimation for primary prevention: validation of a new Sheffield table in the 1995 Scottish health survey population

Por Wallis, Erica J, Ramsay, Lawrence E, Haq, Iftikhar Ul, Ghahramani, Parviz, Jackson, Peter R, Rowland-Yeo, Karen, Yeo, Wilfred W
Publicado em 2000